MRNA vs TRAW · rev $145.0M vs rev $2.8M
Moderna Inc (MRNA) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
MRNA currently screens at market cap $24.52B. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the MRNA and TRAW stock pages for the full models.
Not investment advice.